Mosunetuzumab in Combination With Platinum-Based Salvage Chemotherapy in Patients With Relapsed/Refractory Aggressive B Cell Lymphoma

Clinical trial NCT05464329 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05464329
Sponsor: Washington University School of Medicine
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Large B-cell Lymphoma High-grade B-cell Lymphoma Transformed B-Cell Lymphoma Follicular Lymphoma Grade 3B

Start date: 2023-01-03
Primary completion: 2026-01-02
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.